University of British Columbia, Vancouver, Canada
Barbara Melosky, MD, FRCPC, is a clinical professor of medicine at the University of British Columbia and a medical oncologist at the BC Cancer Center in Vancouver. Dr Melosky specializes in thoracic malignancies and is chair of the Lung Tumor Group at the BC Cancer Center in British Columbia. read more
Dr Melosky sits on the Executive Lung Site Committee for Canadian Cancer Trials Group (CTTG). For the past 18 years, she has chaired the annual Canadian Lung Cancer Conference, attended by over 450 participants.
She is proud to have founded the British Columbia Lung Cancer Biobank, which is actively used for research.
Dr Melosky has published extensively and is considered a national and international expert in thoracic malignancies.
Dr Barbara Melosky discloses: Advisory board or panel fees from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Jazz Pharmaceuticals, Merck, Novartis, Pfizer and Roche.
Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA
Sonia Amin Thomas, PharmD, BCOP is an associate professor of pharmacy practice at the PCOM-Georgia School of Pharmacy and a clinical oncology specialist at Wellstar North Fulton Hospital in Georgia. read more
She attended the University of Georgia for her undergraduate coursework and then proceeded to complete her PharmD at South University School of Pharmacy. Dr Thomas completed a postgraduate year one general pharmacy practice residency in Columbus, Georgia, and received training through a postgraduate year two oncology residency in Detroit, Michigan.
At the PCOM-Georgia School of Pharmacy, she teaches the oncology therapeutics module, clinical reasoning and pharmacogenomics. At Wellstar North Fulton Hospital, she precepts fourth year advanced pharmacy practice experience (APPE) students and postgraduate year one residents on an outpatient/inpatient oncology rotation. She attends a clinic at Northwest Georgia Oncology Centers (NGOC). She is also a graduate of the Institute for Integrative Nutrition (IIN) and a health and wellness nutrition coach for cancer survivors.
Dr Sonia Amin Thomas has no interests/relationships or affiliations to disclose in relation to this activity.
Johns Hopkins University, Baltimore, MD
Christine Argento, MD, is an associate professor of medicine at The Johns Hopkins University in Maryland where she specializes in interventional pulmonology. read more
Dr Argento graduated from St. George’s University School of Medicine in Grenada, completed an internal medicine residency at the University of Medicine and Dentistry in New Jersey, a pulmonary and critical care fellowship at Yale University in Connecticut, and an additional fellowship in interventional pulmonology at Duke University, North Carolina.
Her main focus is on the diagnosis and palliation of patients with lung cancer and evaluation of pulmonary nodules and pleural disease. Her research involves new technologies that further the field of interventional pulmonology, increasing awareness of lung cancer and lung cancer screening, as well as disparities in lung cancer and procedural simulation education.
She is vice president of the Association of Interventional Pulmonary Program Directors (AIPPD), and is a founding and board member of Women in Interventional Pulmonology (WiIP). She also holds leadership roles in national societies such as CHEST and American Thoracic Society (ATS), as well as the American Association of Bronchial and Interventional Pulmonology (AABIP).
Dr Christine Argento discloses: Advisory board or panel fees from Biodesix. Consultancy fees from Biodesix, Boston Scientific, Cook Medical, Intuitive Surgical and Olympus Therapeutics.
Abramson Cancer Center, Hospital of the University of Pennsylvania, PA, USA
Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP, is an adult oncology nurse practitioner for thoracic malignancies at the Abramson Cancer Center at the University of Pennsylvania (UPenn). Dr Sherry is also an advanced senior lecturer at the UPenn School of Nursing where she teaches both undergraduate and graduate students. read more
She earned her bachelor of science in nursing degree at the Catholic University of America, Washington, D.C. and received her master of science in nursing degree at UPenn, from which she graduated as an adult oncology nurse practitioner. She went on to obtain her doctor of nursing practice from Duke University in North Carolina, where her dissertation focused on distress screening and management in patients with metastatic lung cancer.
Dr Sherry is a member of the Oncology Nursing Society (ONS) and the Philadelphia Area Chapter of the ONS. She is also a member of the Xi Chapter of Sigma Teta Thau International Honor Society of Nursing, and the International Thoracic Oncology Nursing Forum (ITONF).
Dr Victoria Sherry discloses: Consultancy fees from AstraZeneca and Boehringer Ingelheim.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.